Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis.
Saved in:
| Title: | Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis. |
|---|---|
| Authors: | Azad TD; Department of Neurosurgery, Johns Hopkins University, Baltimore, MD, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Nanjo S; Department of Medicine, University of California, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan., Jin MC; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA., Chabon JJ; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Kurtz DM; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA., Chaudhuri AA; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., Connolly ID; Department of Neurosurgery, Stanford University, Stanford, CA, USA., Hui AB; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Liu CL; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA., Merriott D; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Ko R; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Yoo C; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Carter J; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Chen E; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Bonilla R; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Hata A; Department of Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan., Katakami N; Department of Medical Oncology, Takarazuka City Hospital, Hyogo, Japan., Irie K; Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University, Kobe, Japan., Yano S; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan., Okimoto R; Department of Medicine, University of California, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Bivona TG; Department of Medicine, University of California, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Newman AM; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA., Iv M; Department of Radiology, Stanford University, Stanford, CA, USA., Nagpal S; Department of Neurology, Stanford University, Stanford, CA, USA., Gephart MH; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., Alizadeh AA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA. arasha@stanford.edu.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA. arasha@stanford.edu.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA. arasha@stanford.edu., Diehn M; Stanford Cancer Institute, Stanford University, Stanford, CA, USA. diehn@stanford.edu.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA. diehn@stanford.edu.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA. diehn@stanford.edu. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2024 May 28; Vol. 8 (1), pp. 121. Date of Electronic Publication: 2024 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-024-00582-1 |
